This newslink doesn't exist or it was removed.
Go to Homempage.
Associated Press USA Business December 12, 2022
Amgen is spending more than $26 billion to dive deeper into rare disease treatments with a deal for drugmaker Horizon Therapeutics. The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a thyroid eye disease treatment that... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | 10 WBNS
Amgen to buy Horizon Therapeutics in $26.4B deal | ABC News
The Boston Globe USA Tech May 17, 2023
The Federal Trade Commission on Tuesday sued to block drugmaker Amgen’s $27.8 billion acquisition of pharmaceutical company Horizon Therapeutics, saying it would thwart competition in the drug industry.The FTC said the deal would allow Amgen to exploit a maneuver known as... + más
Amgen to buy Horizon Therapeutics in $26.4B deal | Associated Press
Fox Business USA Business September 01, 2023
NetChoice Vice President and general counsel Carl Szabo discusses the Biden administration's latest move to gain more control over American businesses on 'The Big Money Show.' The (FTC) will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics,... + más
US sues to block Amgen’s $27.8 billion takeover of Horizon Therapeutics | The Boston Globe
ABC News USA Business May 16, 2023
The U.S. is attempting to block the proposed acquisition of Horizon Therapeutics for more than $26 billion by biotech drug developer Amgen on antitrust grounds. The Federal Trade Commission said Tuesday that the deal, announced in December, would give Amgen unfair leverage to... + más
Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon | ABC News
Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon | Associated Press
ABC News USA Health May 16, 2023
About iurex | Privacy Policy | Disclaimer |